Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Dermatology
»
Psoriasis
22. November 2026
Search
medline.ch
Psoriasis
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 1441
Articles 1 - 20 / 28813
Moderate-to-severe psoriasis in patients with malignancy: A multicentre study.
J Eur Acad Dermatol Venereol
Mataix Díaz FJ, Alarcón SS, Schneller-Pavelescu Apetrei L, García Fernández L, Belinchón Romero I, Ruiz Villaverde R, Baniandrés Rodríguez O, Rodríguez Blanco I, Rivera Díaz R, Hernández Madrid P, Ferrán Farrés M, Salgado Boquete L, Melgosa Ramos FJ, Sahuquillo Torralba A, Cuesta Montero L, Vilarrasa Rull E, López Ferrer A, Delgado JF, Aranegui Arteaga B, Botía Paco A, Ruiz Genao DP, Del Mar Llamas Velasco M, Ballano Ruiz A, Marín Cabañas I, Riera Monroig J, Toledo Alberola F, Pérez Crespo M, Zafrilla EP, Magdaleno Tapial J.
PMID: 43064916 [PubMed - as supplied by publisher]
Real-world effectiveness of roflumilast in psoriasis: results from a Danish-Portuguese multicenter retrospective study.
J Am Acad Dermatol
Nielsen ML, Ferreira C, Thomsen SF, Gyldenløve M, Nissen CV, Luz M, Egeberg A, Torres T.
PMID: 43064167 [PubMed - as supplied by publisher]
Drug survival, treatment discontinuation, and adverse events with off-label oral roflumilast in psoriasis: A retrospective real-world study of 94 patients.
Actas Dermosifiliogr
Tomás Marín A, Armengot-Carbó M.
PMID: 43064028 [PubMed - as supplied by publisher]
Biologic dose reduction versus standard dosing in psoriasis: what is lost and what is gained?
Front Immunol
Peng X, Xu X, Han K, Sun Y.
PMID: 43061428 [PubMed - indexed for MEDLINE]
Clinical characteristics of very early-onset, early-onset and late-onset psoriasis vulgaris in Chinese patients: A multicenter, retrospective study.
JAAD Int
Dong S, Zhao Z, Fan Z, Liu X, Zhao Y, Mu Z, Wang X, Li H, Miao G, Zhang J, Cai L.
PMID: 43061393 [PubMed]
Short-term efficacy and safety of guselkumab for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis with a pasi response-depth analysis.
BMC Pharmacol Toxicol
Maimaitiniyazi M, Maimaitiniyazi M, Maisuti M, Haibier A, Nijiati M.
PMID: 43058953 [PubMed - indexed for MEDLINE]
Beyond BMI categories in psoriatic arthritis: multidimensional characterisation of the normal-weight population.
Expert Rev Clin Immunol
Caso F, Cascone M, Carleo A, Russo M, Balzano A, Tasso M, Ruscitti P, Costa L.
PMID: 43057203 [PubMed - as supplied by publisher]
Apremilast in psoriatic disease: therapeutic outcomes and cardiometabolic trajectories from a multicentre real-world study.
Rheumatol Adv Pract
Terribili R, Trovato E, Gaggiano C, Di Cesare A, Dragotto M, Rosi E, Lepri G, Benucci M, Ricceri F, Delle Sedie A, Baldi C, Rubegni P, Frediani B, Guiducci S, Prignano F, Gentileschi S.
PMID: 43055020 [PubMed]
Lactobacillus acidophilus and Lacticaseibacillus rhamnosus Postbiotics Attenuate Keratinocyte Hyperproliferation and Oxidative Stress and Promote Apoptosis: Potential Implications for Psoriasis.
Int J Microbiol
Fallahi N, Rafiee M, Erfanian N, Namaei MH, Mansouri A, Anani Sarab G.
PMID: 43054351 [PubMed]
Objective assessment and virtual lesion simulation of psoriasis lesion severity based on deep learning regression and generative models.
Front Med (Lausanne)
Zhu L, Ma Z, Qian H, Zhang Y, Zheng P.
PMID: 43054243 [PubMed]
One-Year Real-Life Data From Thai Patients with Moderate-to-Severe Plaque Psoriasis Treated with Secukinumab: Outcomes From the PROMPT Study.
Dermatology
Asawanonda P, Chularojanamontri L, Chuamanochan M, Amornpinyo W, Pongcharoen P, Laodheerasiri S, Pattamadilok B, Choonhakarn C, Sangmala S, Pretikul N, Boonsiri M, Sangob N, Rattanakaemakorn P.
PMID: 43053648 [PubMed - as supplied by publisher]
Shorter Disease Duration Predicts Earlier Complete Skin Clearance in Biologic-naïve Psoriasis Treated with Biologics.
Acta Derm Venereol
Hiura A, Kamata M, Okada Y, Suzuki S, Watanabe A, Chijiwa C, Kubo Y, Mizukawa I, Takeshima R, Hayashi K.
PMID: 43049691 [PubMed - indexed for MEDLINE]
Long-term psoriasis management in older and medically complex patients: The safety, durability, and clinical impact of tildrakizumab.
Dermatol Online J
Shah M, Bartley B, Rosenberg A, DeBusk L, Burshtein J, Zakria D, Armstrong AW, Glick B, Merritt D, Murina A, Romanelli P, Kirsner RS, Daveluy S, Lebwohl M.
PMID: 43048806 [PubMed - indexed for MEDLINE]
Digital health interventions for psoriasis management: a systematic review and meta-analysis of randomized controlled trials.
Front Med (Lausanne)
Zhang J, Wan R, Wang H.
PMID: 43048668 [PubMed]
Implementation and real-world feasibility of a digital psoriasis self-management app: a 12-month prospective observational study.
Front Digit Health
Glatzel C, Steffens O, Kiesel Ö, Strunz PP, Dege T, Leichtfuss L, Bychkova I, Schulze-Hagen T, Stumpf M, Gößwein A, Drews R, Goebeler M, Schmalzing M, Leipe J, Olsavszky V, Schmieder A.
PMID: 43048184 [PubMed]
Palmoplantar Psoriasis, Palmoplantar Pustulosis and Hyperkeratotic Palmoplantar Eczema: A Scoping Review of Clinical and Molecular Characteristics.
Acta Derm Venereol
Johansen MB, Sindrup W, Woetmann A, Zachariae C, Løvendorf M, Skov L.
PMID: 43046599 [PubMed - indexed for MEDLINE]
Ultrasound screening and secukinumab intervention for subclinical and clinical psoriatic arthritis: a prospective real-world study.
Clin Rheumatol
Guo Y, Ma J, Luo S, Li Y, Tu M, Zhou Q, Tong X, Wang H.
PMID: 43045938 [PubMed - as supplied by publisher]
Five-Year Real-World Effectiveness and Drug Survival of Tildrakizumab in Moderate-to-Severe Plaque Psoriasis: A Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis).
Dermatol Ther (Heidelb)
Valenti M, Di Giulio S, Balato A, Bardazzi F, Burlando M, Carrera CG, Carugno A, Cozzani EC, Di Brizzi EV, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Malagoli P, Marzano AV, Mastorino L, Maurelli M, Megna M, Michelucci A, Orsini D, Potestio L, Ribero S, Sacchelli L, Travaglini M, Trovato E, Zerbinati N, Costanzo A, Narcisi A, Ibba L.
PMID: 43043614 [PubMed - as supplied by publisher]
Line-field confocal optical coherence tomography for subclinical monitoring of psoriasis during treatment with biological agents: a pilot study.
Ital J Dermatol Venerol
Verzì AE, Musumeci ML, Puglisi D, Micali G, Lacarrubba F.
PMID: 43043301 [PubMed - indexed for MEDLINE]
From Transdermal Delivery to Immune Reprogramming: Intelligent Biomaterials for Precision Psoriasis Therapy.
Adv Healthc Mater
Jiang X, Lu Y, Hu Z, Wen P, Liu X, Zhou C, Yang F, Hua S, Wu P, Ding Q, Hu X, Liu D.
PMID: 43040914 [PubMed - as supplied by publisher]
Articles 1 - 20 / 28813
Page 1 of 1441
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy